Q4 2024 Management View CEO Adam Steensberg emphasized 2024 as a transformational year for Zealand Pharma, highlighting significant clinical advancements in its obesity pipeline, particularly with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback